News

Dr Catherine Carmichael aims to identify the key mechanisms that drive development of an aggressive form of childhood blood cancer, acute myeloid leukaemia (AML).…  Read more

Through this type of philanthropy, Lions have not just improved the chances of children with cancer living longer and better lives. Lions have also improved the likelihood that the next major breakthrough in paediatric cancer will come from Hudson Institute in Australia.…  Read more

There are few parts of the Australian community that remain untouched by ovarian cancer. The team at Spotlight Group Holdings, one of the nation’s largest retail organisations, is supporting Hudson Institute’s work to help find a cure and better early diagnostics for the deadly disease.…  Read more

The Academy welcomed the new Fellows, which included Hudson Institute Director and CEO, Professor Elizabeth Hartland AM, in a ceremony at its Annual Meeting.…  Read more

Associate Professor Jun Yang has been recognised as a change agent in the field of hypertension research and treatment, with the Victorian government adding her to the state’s official Honour Roll of Women.…  Read more

Hudson Institute of Medical Research is mourning the passing of one of its founding fathers, Henry G Burger AO.…  Read more

At Hudson Institute, Minister for Medical Research Ben Carroll announced the establishment of the Victorian Paediatric Cancer Consortium Limited (VPCC Ltd), made possible by a $35 million investment from the Government and $10 million from the Children’s Cancer Foundation.…  Read more

Unprecedented access to a unique group of Australians is allowing researchers to study links between raised aldosterone levels and elevated cardiovascular risk in various age groups – with important findings for heart health. This research is shedding new light on aldosterone heart risk, a critical factor in cardiovascular health.…  Read more

BioCurate’s Proof of Concept Fund is working to change this trend by providing crucial support to address critical gaps in promising projects, as exemplified by the groundbreaking work on Interleukin-38 (IL-38) led by Professor Claudia Nold from Hudson Institute of Medical Research and Associate Professor Andrew Ellisdon from the Monash Biomedicine Discovery Institute.…  Read more

Faced with a condition that’s rarely spoken about, despite affecting up to 40 percent of all women, Sally decided things had to change, so she volunteered to be our POP advocate – sharing her story and her suffering to help avoid others going through the same thing.…  Read more